Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionhistone binding

SMARCA2 PHF2 RBBP5 CHD3

1.00e-04265194GO:0042393
GeneOntologyMolecularFunctionATP-dependent chromatin remodeler activity

SMARCA2 CHD3

5.60e-0437192GO:0140658
GeneOntologyBiologicalProcesschromatin organization

SMARCA2 PHF2 RBBP5 HMGN4 CHD3 BAHCC1

7.82e-05896186GO:0006325
GeneOntologyBiologicalProcessprotein-DNA complex organization

SMARCA2 PHF2 RBBP5 HMGN4 CHD3 BAHCC1

1.43e-04999186GO:0071824
HumanPhenoPeriorbital wrinkles

SMARCA2 EDA

1.62e-05572HP:0000607
HumanPhenoEnamel hypoplasia

SMARCA2 EDA CHD3

2.73e-0410473HP:0006297
HumanPhenoShort distal phalanx of finger

SMARCA2 EDA PTHLH

4.06e-0411973HP:0009882
HumanPhenoAplasia/Hypoplasia of the distal phalanges of the hand

SMARCA2 EDA PTHLH

4.59e-0412473HP:0009835
HumanPhenoWidely spaced teeth

SMARCA2 EDA CHD3

4.70e-0412573HP:0000687
HumanPhenoHypoplasia of teeth

SMARCA2 EDA CHD3

4.81e-0412673HP:0000685
HumanPhenoAbnormality of teeth spacing

SMARCA2 EDA CHD3

4.92e-0412773HP:0006478
DomainSNF2_N

SMARCA2 CHD3

4.28e-0432182PF00176
DomainSNF2_N

SMARCA2 CHD3

4.28e-0432182IPR000330
Domain-

HMGB3 CHD3

1.26e-03551821.10.30.10
DomainZinc_finger_PHD-type_CS

PHF2 CHD3

1.76e-0365182IPR019786
DomainHMG_box_dom

HMGB3 CHD3

1.76e-0365182IPR009071
DomainPHD

PHF2 CHD3

2.34e-0375182PF00628
DomainZnf_PHD-finger

PHF2 CHD3

2.59e-0379182IPR019787
DomainPHD

PHF2 CHD3

3.27e-0389182SM00249
DomainZnf_PHD

PHF2 CHD3

3.41e-0391182IPR001965
DomainZF_PHD_2

PHF2 CHD3

3.71e-0395182PS50016
DomainZF_PHD_1

PHF2 CHD3

3.79e-0396182PS01359
DomainHelicase_C

SMARCA2 CHD3

4.69e-03107182PF00271
DomainHELICc

SMARCA2 CHD3

4.69e-03107182SM00490
DomainHelicase_C

SMARCA2 CHD3

4.77e-03108182IPR001650
DomainHELICASE_CTER

SMARCA2 CHD3

4.86e-03109182PS51194
DomainHELICASE_ATP_BIND_1

SMARCA2 CHD3

4.86e-03109182PS51192
DomainDEXDc

SMARCA2 CHD3

4.86e-03109182SM00487
DomainHelicase_ATP-bd

SMARCA2 CHD3

4.95e-03110182IPR014001
Domain-

PHF2 CHD3 TRIM56

8.61e-034491833.30.40.10
DomainZnf_FYVE_PHD

PHF2 CHD3

8.67e-03147182IPR011011
DomainZnf_RING/FYVE/PHD

PHF2 CHD3 TRIM56

9.14e-03459183IPR013083
PathwayREACTOME_CHROMATIN_MODIFYING_ENZYMES

SMARCA2 PHF2 RBBP5 CHD3

5.94e-05272124M29619
PathwayWP_KLEEFSTRA_SYNDROME

SMARCA2 RBBP5

2.66e-0429122M48076
PathwayREACTOME_CHROMATIN_MODIFYING_ENZYMES

PHF2 RBBP5 CHD3

3.81e-04175123MM14941
PathwayWP_RETT_SYNDROME

SMARCA2 SRRM3

7.33e-0448122M39759
PathwayREACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION

SMARCA2 RBBP5 CHD3

1.13e-03254123M27131
Pubmed

Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression.

SMARCA2 PHF2 CHD3 RRP12

2.29e-085619426919559
Pubmed

Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.

SMARCA2 PHF2 HMGN4 HMGB3 CHD3 RRP12

2.89e-0753319630554943
Pubmed

Human transcription factor protein interaction networks.

SMARCA2 PHF2 RBBP5 HMGB3 ELF3 CHD3 RRP12 EBNA1BP2

4.01e-07142919835140242
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

SMARCA2 PHF2 ELF3 CHD3 TRIM56 EBNA1BP2 BAHCC1

1.24e-06111619731753913
Pubmed

Ectodysplasin regulates hormone-independent mammary ductal morphogenesis via NF-κB.

EDA PTHLH

7.90e-06819222451941
Pubmed

SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.

SMARCA2 PHF2 CHD3 RRP12

9.28e-0625019433536335
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

PHF2 RBBP5 HMGB3 CHD3 EBNA1BP2

1.52e-0560819536089195
Pubmed

Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.

SMARCA2 CHD3

1.55e-051119210204490
Pubmed

Ectodysplasin target gene Fgf20 regulates mammary bud growth and ductal invasion and branching during puberty.

EDA PTHLH

3.38e-051619228698625
Pubmed

Ectodysplasin/NF-κB Promotes Mammary Cell Fate via Wnt/β-catenin Pathway.

EDA PTHLH

3.38e-051619226581094
Pubmed

Transcriptomic landscape of early hair follicle and epidermal development.

EDA PTHLH

4.30e-051819237318953
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

PHF2 RBBP5 HMGN4 CHD3 RRP12 EBNA1BP2

4.69e-05129419630804502
Pubmed

WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.

RBBP5 CHD3 RRP12 EBNA1BP2

5.50e-0539419427248496
Pubmed

ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.

SMARCA2 CHD3

5.90e-052119212453419
Pubmed

Genome-wide association studies identify four ER negative-specific breast cancer risk loci.

ZNF365 PTHLH

5.90e-052119223535733
Pubmed

The histone acetyltransferase KAT6A is recruited to unmethylated CpG islands via a DNA binding winged helix domain.

HMGN4 CHD3 RRP12 EBNA1BP2

6.85e-0541719436537216
Pubmed

The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.

SMARCA2 PHF2 CHD3

8.29e-0515719330186101
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

SMARCA2 PHF2 RBBP5 EPS8 TRIM56 RRP12

1.05e-04149719631527615
Pubmed

Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg.

ELF3 PTHLH

1.14e-042919226097038
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

PHF2 HMGN4 HMGB3 CHD3 EBNA1BP2

1.30e-0495419536373674
Pubmed

Lhx2 is a direct NF-κB target gene that promotes primary hair follicle placode down-growth.

EDA PTHLH

1.48e-043319226952977
Pubmed

Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.

SMARCA2 RBBP5 HMGN4 HMGB3 CHD3

1.73e-04101419532416067
Pubmed

Spatiotemporal single-cell regulatory atlas reveals neural crest lineage diversification and cellular function during tooth morphogenesis.

FST PTHLH

1.86e-043719235974052
Pubmed

DEAD-box helicase DDX27 regulates 3' end formation of ribosomal 47S RNA and stably associates with the PeBoW-complex.

RRP12 EBNA1BP2

2.07e-043919225825154
Pubmed

Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.

SMARCA2 RBBP5 CHD3 EBNA1BP2

2.46e-0458219420467437
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

SMARCA2 PHF2 HMGN4 HMGB3 CHD3

2.55e-04110319534189442
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

SMARCA2 CHD3 RRP12 EBNA1BP2

2.85e-0460519428977666
Pubmed

Age-associated alteration of gene expression patterns in mouse oocytes.

SMARCA2 HMGB3

3.55e-045119215317747
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

CHD3 TRIM56 RRP12 EBNA1BP2

3.86e-0465519435819319
Pubmed

Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.

SMARCA2 RBBP5 CHD3

4.00e-0426819333640491
Pubmed

Genetic variants associated with breast size also influence breast cancer risk.

ZNF365 PTHLH

4.43e-045719222747683
Pubmed

The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.

SMARCA2 EPS8 CHD3

4.64e-0428219323667531
Pubmed

The functional interactome landscape of the human histone deacetylase family.

CHD3 RRP12 EBNA1BP2

4.99e-0428919323752268
Pubmed

A lentiviral functional proteomics approach identifies chromatin remodeling complexes important for the induction of pluripotency.

SMARCA2 RBBP5

5.08e-046119220305087
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

HMGB3 CHD3 RRP12 EBNA1BP2

5.34e-0471419428302793
InteractionLHX2 interactions

SMARCA2 PHF2 RBBP5 HMGB3 RRP12 EBNA1BP2

1.27e-08183196int:LHX2
InteractionPARP1 interactions

SMARCA2 PHF2 HMGN4 ZNF365 HMGB3 CHD3 TRIM56 RRP12 EBNA1BP2

1.07e-061316199int:PARP1
InteractionSAP18 interactions

SMARCA2 RBBP5 CHD3 TRIM56 EBNA1BP2

7.51e-06305195int:SAP18
InteractionH3C1 interactions

SMARCA2 RBBP5 HMGN4 HMGB3 CHD3 RRP12 EBNA1BP2

1.10e-05901197int:H3C1
InteractionSAP30 interactions

SMARCA2 RBBP5 CHD3 BAHCC1

1.60e-05167194int:SAP30
InteractionCENPA interactions

SMARCA2 PHF2 CHD3 RRP12 EBNA1BP2

2.09e-05377195int:CENPA
InteractionSSRP1 interactions

PHF2 RBBP5 HMGN4 HMGB3 REXO1 CHD3

2.80e-05685196int:SSRP1
InteractionH2BC3 interactions

RBBP5 HMGN4 CHD3 RRP12 EBNA1BP2

2.98e-05406195int:H2BC3
InteractionSUPT16H interactions

SMARCA2 RBBP5 HMGN4 HMGB3 CHD3

4.47e-05442195int:SUPT16H
InteractionZNF330 interactions

PHF2 HMGB3 CHD3 RRP12 EBNA1BP2

4.67e-05446195int:ZNF330
InteractionRSL1D1 interactions

SMARCA2 ELF3 CHD3 RRP12 EBNA1BP2

6.56e-05479195int:RSL1D1
InteractionNOC3L interactions

HMGN4 CHD3 RRP12 EBNA1BP2

7.04e-05244194int:NOC3L
InteractionH3C3 interactions

PHF2 RBBP5 HMGB3 CHD3 EBNA1BP2

7.66e-05495195int:H3C3
InteractionNOC2L interactions

EDA CHD3 RRP12 EBNA1BP2

1.23e-04282194int:NOC2L
InteractionSMARCE1 interactions

SMARCA2 RBBP5 EPS8 CHD3

1.32e-04287194int:SMARCE1
InteractionNOP56 interactions

SMARCA2 PHF2 CHD3 RRP12 EBNA1BP2

1.49e-04570195int:NOP56
InteractionH2BC8 interactions

PHF2 RBBP5 HMGB3 CHD3 EBNA1BP2

1.56e-04576195int:H2BC8
InteractionNOP58 interactions

RBBP5 CHD3 RRP12 EBNA1BP2

1.75e-04309194int:NOP58
InteractionSOX2 interactions

SMARCA2 RBBP5 EPS8 CHD3 TRIM56 RRP12 EBNA1BP2

2.03e-041422197int:SOX2
InteractionCIT interactions

SMARCA2 PHF2 EDA RBBP5 CHD3 RRP12 EBNA1BP2

2.29e-041450197int:CIT
InteractionCXXC1 interactions

SMARCA2 EDA RBBP5

2.46e-04132193int:CXXC1
InteractionMYB interactions

SMARCA2 RBBP5 CHD3

2.52e-04133193int:MYB
InteractionH1-4 interactions

RBBP5 CHD3 TRIM56 RRP12 EBNA1BP2

2.86e-04656195int:H1-4
InteractionPAX6 interactions

SMARCA2 RBBP5 HMGB3 CHD3

3.34e-04366194int:PAX6
InteractionSLFN11 interactions

SMARCA2 PHF2 CHD3 RRP12

3.70e-04376194int:SLFN11
InteractionSIN3A interactions

SMARCA2 EDA RBBP5 CHD3

3.85e-04380194int:SIN3A
InteractionGNL2 interactions

RBBP5 HMGN4 CHD3 RRP12

4.09e-04386194int:GNL2
InteractionTWIST1 interactions

PHF2 CHD3 EBNA1BP2

5.17e-04170193int:TWIST1
InteractionTGIF2LX interactions

RBBP5 BAHCC1

5.20e-0436192int:TGIF2LX
InteractionEGR2 interactions

SMARCA2 RBBP5 BAHCC1

5.26e-04171193int:EGR2
InteractionSMARCA5 interactions

SMARCA2 RBBP5 HMGN4 CHD3

5.37e-04415194int:SMARCA5
InteractionCPSF2 interactions

SMARCA2 RBBP5 CHD3

5.44e-04173193int:CPSF2
InteractionCHD3 interactions

SMARCA2 RBBP5 CHD3 RRP12 EBNA1BP2

5.53e-04757195int:CHD3
InteractionFTSJ3 interactions

HMGN4 CHD3 RRP12 EBNA1BP2

5.72e-04422194int:FTSJ3
InteractionTEAD1 interactions

SMARCA2 RBBP5 CHD3

5.72e-04176193int:TEAD1
InteractionBRD2 interactions

SMARCA2 PHF2 HMGN4 CHD3

6.09e-04429194int:BRD2
InteractionKLHL36 interactions

HMGN4 KLHL36

6.11e-0439192int:KLHL36
InteractionNIFK interactions

RBBP5 CHD3 RRP12 EBNA1BP2

6.20e-04431194int:NIFK
InteractionCEBPA interactions

SMARCA2 PHF2 HMGN4 HMGB3 CHD3 RRP12

7.41e-041245196int:CEBPA
InteractionSRRM2 interactions

SMARCA2 SRRM3 EDA RBBP5

8.04e-04462194int:SRRM2
InteractionADNP interactions

SMARCA2 CHD3 EBNA1BP2

8.18e-04199193int:ADNP
InteractionCCDC137 interactions

HMGN4 CHD3 EBNA1BP2

8.30e-04200193int:CCDC137
InteractionMRTO4 interactions

CHD3 RRP12 EBNA1BP2

8.30e-04200193int:MRTO4
InteractionPRMT5 interactions

SMARCA2 PHF2 RBBP5 RRP12

8.64e-04471194int:PRMT5
InteractionPSIP1 interactions

RBBP5 HMGB3 CHD3

8.91e-04205193int:PSIP1
InteractionRAN interactions

SMARCA2 RBBP5 CHD3 EBNA1BP2

8.91e-04475194int:RAN
InteractionDDX23 interactions

PHF2 CHD3 RRP12 EBNA1BP2

9.27e-04480194int:DDX23
InteractionTPRN interactions

SMARCA2 EPS8

9.64e-0449192int:TPRN
InteractionBRD3 interactions

SMARCA2 PHF2 HMGN4 HMGB3

1.03e-03494194int:BRD3
InteractionSRSF6 interactions

CHD3 TRIM56 RRP12 EBNA1BP2

1.10e-03503194int:SRSF6
InteractionRBM19 interactions

HMGN4 RRP12 EBNA1BP2

1.11e-03221193int:RBM19
InteractionH2AC4 interactions

RBBP5 CHD3 RRP12 EBNA1BP2

1.13e-03506194int:H2AC4
InteractionRBBP7 interactions

SMARCA2 RBBP5 CHD3 BAHCC1

1.14e-03507194int:RBBP7
InteractionKAT6A interactions

HMGN4 CHD3 RRP12 EBNA1BP2

1.16e-03510194int:KAT6A
InteractionNSA2 interactions

CHD3 EBNA1BP2 BAHCC1

1.17e-03225193int:NSA2
InteractionSYMPK interactions

SMARCA2 RBBP5 CHD3

1.17e-03225193int:SYMPK
InteractionELF3 interactions

ELF3 EBNA1BP2

1.17e-0354192int:ELF3
InteractionKLF3 interactions

SMARCA2 RBBP5 CHD3

1.21e-03228193int:KLF3
InteractionGPATCH4 interactions

CHD3 RRP12 EBNA1BP2

1.27e-03232193int:GPATCH4
InteractionRPS24 interactions

PHF2 CHD3 RRP12 EBNA1BP2

1.33e-03529194int:RPS24
InteractionXRCC6 interactions

PHF2 HMGN4 EPS8 ELF3 CHD3

1.39e-03928195int:XRCC6
InteractionTAF6 interactions

SMARCA2 RBBP5 CHD3

1.49e-03245193int:TAF6
InteractionMAFB interactions

RBBP5 RRP12 EBNA1BP2

1.51e-03246193int:MAFB
InteractionPUM3 interactions

HMGN4 CHD3 EBNA1BP2

1.65e-03254193int:PUM3
InteractionCRX interactions

SMARCA2 RBBP5 BAHCC1

1.65e-03254193int:CRX
InteractionRIOK1 interactions

CHD3 TRIM56 RRP12 EBNA1BP2

1.66e-03562194int:RIOK1
InteractionPBRM1 interactions

SMARCA2 ELF3 CHD3

1.73e-03258193int:PBRM1
InteractionFGF3 interactions

RRP12 EBNA1BP2

1.74e-0366192int:FGF3
InteractionH2BC4 interactions

SMARCA2 RRP12 EBNA1BP2

1.75e-03259193int:H2BC4
InteractionRRP8 interactions

HMGN4 RRP12 EBNA1BP2

1.75e-03259193int:RRP8
InteractionTAF1 interactions

SMARCA2 RBBP5 CHD3

1.77e-03260193int:TAF1
InteractionTOP3B interactions

HMGN4 KLHL36 REXO1 TRIM56 RRP12 BAHCC1

1.77e-031470196int:TOP3B
InteractionRBBP4 interactions

SMARCA2 RBBP5 CHD3 BAHCC1

1.78e-03573194int:RBBP4
InteractionREXO4 interactions

CHD3 RRP12 EBNA1BP2

1.78e-03261193int:REXO4
InteractionPOU5F1 interactions

SMARCA2 RBBP5 CHD3 RRP12

1.91e-03584194int:POU5F1
InteractionSMC5 interactions

PHF2 HMGN4 HMGB3 CHD3 EBNA1BP2

1.93e-031000195int:SMC5
InteractionRPL13A interactions

RBBP5 CHD3 TRIM56 EBNA1BP2

2.00e-03591194int:RPL13A
InteractionDDX24 interactions

HMGN4 CHD3 RRP12 EBNA1BP2

2.06e-03596194int:DDX24
InteractionHNF4A interactions

SMARCA2 RBBP5 CHD3

2.07e-03275193int:HNF4A
InteractionARID1A interactions

SMARCA2 RBBP5 CHD3

2.09e-03276193int:ARID1A
InteractionUSP36 interactions

RBBP5 CHD3 RRP12 EBNA1BP2

2.10e-03599194int:USP36
InteractionCREBBP interactions

SMARCA2 RBBP5 ELF3 CHD3

2.10e-03599194int:CREBBP
CytobandEnsembl 112 genes in cytogenetic band chr1q32

RBBP5 ELF3

6.33e-03290192chr1q32
GeneFamilyCanonical high mobility group

HMGN4 HMGB3

2.21e-0511122511
GeneFamilyPHD finger proteins

PHF2 CHD3

1.57e-039012288
ToppCell3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SMARCA2 FST EPS8 CHD3

1.31e-06197194ad6c200a193a15360d17463e18a465ce1b90b8da
ToppCell3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.4.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SRRM3 HMGB3 ELF3

4.91e-05170193fed8e982d2ce234c59d4016432ed8941df36df27
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type.

PHF2 EDA PTHLH

5.35e-051751932812ac2ef41d245db544697fb6da1883361c96e8
ToppCellEpithelial-basal_cell|World / Lineage, Cell type, age group and donor

HMGB3 ELF3 PTHLH

5.73e-05179193d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCellCOVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type

EPS8 HMGB3 ELF3

6.73e-0518919384d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCelldroplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FST EDA PTHLH

7.16e-0519319364edc1d6fb0fe117767d494cf4a5723bf8be2804
ToppCellfacs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SMARCA2 FST EPS8

7.49e-05196193c936014125b2ed5f796221b74acb77b8f8359875
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EDA KLHL36 CHD3

7.61e-051971939f0d91bb7aec4f2442259eca1ddf7905f8d40e9b
ToppCellCOVID-19_Severe-Lymphoid_T/NK-CD4+_T_naive|COVID-19_Severe / Disease group, lineage and cell class

EDA KLHL36 CHD3

7.61e-0519719307f74bdadfd28e1d55b3f4a3bf87d5dd65a2e9c5
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

EDA KLHL36 CHD3

7.61e-05197193bf80e39cd68fd5bb85c8726d4f82648391de74ad
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

EDA KLHL36 CHD3

7.61e-05197193296b27348ca7e9acf746f752cf810e4e5baea76c
ToppCellPBMC-Severe-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

EDA KLHL36 CHD3

7.61e-05197193258dfe69b5faeaee709422f873b144ca5e4a6452
ToppCell(11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition

SMARCA2 EPS8 EBNA1BP2

7.72e-0519819376d40b8c2f8399725b3a62ee2ae0896559cf91eb
ToppCellBronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X

SMARCA2 HMGB3 ELF3

7.72e-05198193f5b7013045b61fc56894f80092f799770dde1c8f
ToppCelltumor_Lung-Epithelial_cells-tS2|tumor_Lung / Location, Cell class and cell subclass

EPS8 HMGB3 ELF3

7.84e-0519919328ec59e01061287fb0892491790b316e2b93e232
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

HMGB3 ELF3 PTHLH

7.84e-051991933c3133d0aa65338a576634def13e7f0f5c573a10
ToppCellhuman_hepatoblastoma-Tumor_cells-T9|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

EPS8 ELF3 RRP12

7.84e-05199193e9c83555d2197b740797a9f33b64f8f7a7ba1ee2
ToppCellParenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

HMGB3 ELF3 PTHLH

7.84e-05199193a706ad5cd5e0dc8d7e925a05e45b07d35963f294
ToppCellBrain_organoid-organoid_Tanaka_cellReport-10w-Neuronal|10w / Sample Type, Dataset, Time_group, and Cell type.

SRRM3 HMGB3 CHD3

7.96e-05200193979258173b82f37aeaaedd53b4a527da1dbe1b80
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FST HMGB3 ELF3

7.96e-0520019341705bbba40eb5ddca0b223191aac1bce00163b8
ToppCellTracheal-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FST HMGB3 ELF3

7.96e-052001939da214f756a03516eaafde00289b90f69623b9f3
ToppCellParenchyma_COVID-19-Epithelial-TX-Basal_3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

FST HMGB3 ELF3

7.96e-0520019353e04399d0308b40ae99fbfaa4ff62bf061822d8
ToppCellParenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

FST HMGB3 ELF3

7.96e-05200193592c7c3ded409a9957cbcdc62fcc213fa8eae598
ToppCellBronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type

EPS8 HMGB3 ELF3

7.96e-05200193f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCellBronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FST HMGB3 ELF3

7.96e-052001930594ca7bc313b73e1dc800cf058f8f798b0284cb
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_naive|COVID-19_Severe / Disease, condition lineage and cell class

EDA KLHL36 CHD3

7.96e-052001931fb96090b5205e95ec21378bf4b88eec7257cf7e
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

FST HMGB3 ELF3

7.96e-0520019361811380d9252f12f27b7ad4752380b52692677f
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_3|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

FST HMGB3 ELF3

7.96e-05200193cc8df398532c9324fd3e171000b1ea5c208cd691
ToppCellLung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

FST HMGB3 ELF3

7.96e-052001938cfbde43c5e66269ad128aa5398b1517667d7d36
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))|Entopeduncular / BrainAtlas - Mouse McCarroll V32

FST KLHL36

9.51e-04108192ba83418023d9d296b0edd4c4e1832a33bc9b3b69
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))--|Entopeduncular / BrainAtlas - Mouse McCarroll V32

FST KLHL36

9.51e-04108192a93a427ab16628c86db3bb17bfecf801f56ce270
ToppCellEntopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pmch_(Lateral_hypothalamus_(LH))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32

FST KLHL36

9.51e-04108192673da75b24218557d01ee461a13c426040da74b9
ToppCellCOVID_vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_vent / Disease condition, Lineage, Cell class and subclass

EDA PTHLH

1.29e-03126192a1ea8cf6b444a640544d204dfaf5ff219dc31aa9
ToppCellFrontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Nptxr-Excitatory_Neuron.Slc17a7.Nptxr-Calb1_(Superficial_layer_pyramidal_cells--Layer_2/3)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32

SMARCA2 FST

1.29e-031261927dcc79bf35482e8e5e5a1de7279ba080edb70522
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1-AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ELF3 EBNA1BP2

1.41e-03132192c6bf0b4b9e33b517629faf4559a21d7ba720ee6a
ToppCell10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SRRM3 HMGB3

1.41e-03132192634b69a20939ecb6aa9e00a22dfcd6ba781d4e73
ToppCellNS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

FST ELF3

1.50e-031361927f1ca43e0d164b511120316d4218d80ba21a9b5c
ToppCellChildren_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

HMGB3 ELF3

1.66e-0314319228e936c298a45f88d14f0146caf3d5a22d483cd5
ToppCellSevere-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CHD3 BAHCC1

1.70e-03145192a24cad86509208bc7267b02ef1d1b0a25a2a7043
ToppCellP15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EPS8 ELF3

1.75e-03147192aba44c7057096483c4293a7ebcf8ccc8baed0231
ToppCellFetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

EPS8 ELF3

1.77e-031481929fe3c0a5904b8e9a0f28130f8d84d4f2a819b06c
ToppCelldroplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CHD3 TRIM56

1.80e-0314919265778f19599b4955c0a16f0121237656449431fb
ToppCell367C-Lymphocytic-NK_cells-NK_cell_B0|367C / Donor, Lineage, Cell class and subclass (all cells)

RBBP5 REXO1

1.80e-0314919241f28138bde45d0b814e116837e5a32b5e80d54a
ToppCellNasal_Brush-Epithelial-Club|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

SRRM3 BAHCC1

1.82e-03150192c68645ffcffe524cf1d9736cf72a15b37ed8dc3d
ToppCellNasal_Brush-Epithelial-Club|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

SRRM3 BAHCC1

1.82e-03150192d39d73a1de6a873292d48e469d9403f513045be3
ToppCellInt-URO-Lymphocyte-T_NK-CD4_CTL|Int-URO / Disease, Lineage and Cell Type

EDA ZNF365

1.89e-03153192fdc7dfa8f4db90bfdc7180bf178cf6d2dd064d97
ToppCellLeuk-UTI-Lymphocyte-T_NK-Treg|Leuk-UTI / Disease, Lineage and Cell Type

FST ZNF365

1.89e-03153192b24c693b142206d13b29c96faa7f79a1a22bc2ef
ToppCellPBMC-Control-cDC_8|Control / Compartment, Disease Groups and Clusters

EDA RBBP5

1.89e-03153192db1a6914f2033fb0748e0523cffe5d6dc4e901be
ToppCellAdult-Epithelial-basal_cell-D122|Adult / Lineage, Cell type, age group and donor

FST HMGB3

1.92e-0315419238d346402417960044ae999e61f0092b46f2b591
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

ZNF365 PTHLH

1.99e-03157192b9d04ee417c0d8ea0801d10f1c54e138587009fd
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

EPS8 ELF3

2.01e-03158192debebc8534a80e5500051f6fd352dc201585968d
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EPS8 PTHLH

2.07e-0316019286fde32f096eaf9ea3677f57169cdcc0a57bb8dd
ToppCellfacs-Thymus-Flowthrough-24m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM3 ELF3

2.12e-03162192b4adb9c053e02e71b0f1a6e7ab6dddc34a7245e0
ToppCellfacs-Thymus-Flowthrough-24m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM3 ELF3

2.12e-0316219296c8ed9d9cb1cf4175c2f41a6e4ebe02a378044c
ToppCellfacs-Thymus-Flowthrough-24m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SRRM3 ELF3

2.12e-03162192ebce09d96e02820ce7d33ad3f417586f96efed76
ToppCellTCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9

FST PTHLH

2.17e-03164192de1646dbcf2a10b48e021acf7dc63e803e6a47ce
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-2_VIP_PPAPDC1A|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

ELF3 PTHLH

2.17e-03164192e1032c406325873206c588ecdbee587d3e37e0ec
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CHD3 TRIM56

2.19e-03165192eeb58d4db64ad37dc6b441eab22b05c24862e1a9
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EPS8 PTHLH

2.19e-03165192369d77a80d6401e85ea3121ab5a252f67d5f157e
ToppCellIonocyte-iono-3|World / Class top

FST ZNF365

2.22e-031661929c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCellSomatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EPS8 PTHLH

2.22e-03166192688e3c01ffcec01eb7027df6f3bde8fecfb50479
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

EPS8 ELF3

2.22e-03166192c20479fe7a4306320d7f26e78bf956225f00f35a
ToppCell5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HMGB3 ELF3

2.22e-031661929e98e6070055bfc780becee52d77830e06b6d854
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SRRM3 ZNF365

2.25e-031671923edb0570e583bb527165bcd8a4c25a042054043b
ToppCellFetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ELF3 PTHLH

2.27e-031681926521bead9789d626b86cbd08692c621c5a5aef33
ToppCell10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

SMARCA2 ZNF365

2.27e-0316819207be11b6f0f37106e219692db5795c6dd32807c9
ToppCellFetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ELF3 PTHLH

2.30e-03169192c3ee781735a9288ce1822b230d39bb91c1415589
ToppCellChildren_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SRRM3 HMGB3

2.30e-0316919296a2aec9acf8a6f966973c035e5ade456cf47772
ToppCell5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HMGB3 ELF3

2.30e-03169192d59c8cd0719ed0947d42da9e7e5da72ff58ecc0d
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FST PTHLH

2.33e-031701922d880223d01bde4bf777bd6f50b7d2768489075f
ToppCellfacs-Brain_Myeloid-Striatum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FST EDA

2.33e-03170192ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2
ToppCell5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FST PTHLH

2.33e-031701920cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCellAdult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor

EPS8 ELF3

2.33e-03170192269dee5abca9f6aa079f116f0d8f1d198604d9d4
ToppCellP03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

EPS8 ELF3

2.33e-031701923fd37e9b377d6485cea1262c31a8507d18a78514
ToppCellfacs-Brain_Myeloid-Striatum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FST EDA

2.33e-03170192b6882665a27c78a63f3b4a2a8806c8438a98e407
ToppCellfacs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FST EDA

2.33e-03170192626c12b9a51218f72ee32afb5fd5d4b075025d75
ToppCellfacs-Brain_Myeloid-Striatum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FST EDA

2.33e-0317019231daac8696ae8c021c0302d3b30dd8194054b3e7
ToppCell5'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HMGB3 ELF3

2.38e-031721927e94ff45812f0d03829976339240f3e4ba557122
ToppCell3'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HMGB3 ELF3

2.38e-0317219263a91974b12c3f7f0c6bf66c30088d7fc07f5cea
ToppCell5'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HMGB3 ELF3

2.38e-031721924f4d39d26c40524dbdce39334dddd0eb30c140b2
ToppCellfacs-Brain_Non-Myeloid-Striatum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HMGB3 BAHCC1

2.38e-0317219235c20de4db47dbf31c857d23c7a25cd7f95c085c
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FST ELF3

2.44e-03174192207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell10x5'-lymph-node_spleen-Hematopoietic_progenitors|lymph-node_spleen / Manually curated celltypes from each tissue

HMGB3 BAHCC1

2.44e-03174192029394e107bf7ad58056d2216070aa2e964fff12
ToppCellSevere-B_naive-8|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CHD3 BAHCC1

2.44e-03174192f3f8c924420f46321bd47e2b97f18c7241541599
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RBBP5 ELF3

2.44e-0317419242f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCellwk_15-18-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

FST PTHLH

2.46e-03175192a84965d28438a4228d841b357c2cd75cf4b59a63
ToppCellfacs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

RRP12 BAHCC1

2.46e-03175192aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SRRM3 HMGB3

2.46e-031751923031f1eef3cfef8a7e5f57e567cb0868d06cac38
ToppCellAnterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

EPS8 PTHLH

2.46e-031751925a9160a9d05e01d945e77fd81bb0bd87139545cd
ToppCell367C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells)

EDA HMGB3

2.46e-03175192bde785ff0c854646d7ab8571359e9d69a7bf013f
ToppCellNasal_Brush-Epithelial-Basal_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X

FST PTHLH

2.49e-03176192fc5787946f5a10056d326d070620575ae4081836
ToppCellNasal_Brush-Epithelial-Basal_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X

FST PTHLH

2.49e-031761925daaba0853afe7d20d4635169ccd4f96e735b938
ToppCellwk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

FST PTHLH

2.49e-031761921af28b701c4598ce761f85adbd5d79e4918d265a
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SRRM3 FST

2.49e-03176192e2b59a904c5c8f9c88e1e63788e9b6485f22edd0
ToppCelldroplet-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

SRRM3 FST

2.49e-03176192f931192e3cc65414e2245354f443473696cc7ce8
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

EPS8 ELF3

2.49e-031761923bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCellTCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9

FST PTHLH

2.52e-03177192a0c7d08469c513cecf87777c19876884f1511570
ToppCellPND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HMGB3 ELF3

2.52e-031771923081ce5fc66a1bb833719d6c0e0a6fc7115eeb91
ToppCell3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SRRM3 HMGB3

2.52e-031771928c6d8a1c469346e66f9095d86b4615f8fc611362
ToppCell3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Enterocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

EDA ELF3

2.52e-031771921f5b6498364b2017c4d49cd337d6e91c8e4f840d
Drugtrimethylsilyldiazomethane

EDA HMGN4

9.88e-066192CID000167693
DrugAC1O3MN8

EDA HMGN4

1.38e-057192CID006332297
Drugtrichostatin A; Down 200; 0.1uM; PC3; HG-U133A

FST PHF2 PTHLH CHD3

1.55e-05187194448_DN
Drugretinoic acid; Down 200; 1uM; HL60; HG-U133A

FST CHD3 RRP12 BAHCC1

1.87e-05196194390_DN
Drug5286656; Down 200; 50uM; MCF7; HT_HG-U133A_EA

SMARCA2 ELF3 CHD3 BAHCC1

1.94e-05198194889_DN
DrugVerapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HT_HG-U133A

EDA KLHL36 ELF3 BAHCC1

1.98e-051991946287_UP
DrugNovobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; HL60; HT_HG-U133A

FST EDA PTHLH RRP12

1.98e-051991942990_UP
DrugNSC-312017

FST HMGN4

3.61e-0511192CID000432667
DrugAC1L1BNF

EDA HMGN4

1.80e-0424192CID000001522
Drug2-thienylalanine

EDA PTHLH

2.29e-0427192CID000091444
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.21e-041631937285_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.63e-041701933791_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST KLHL36 PTHLH

3.63e-041701933746_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.82e-041731935950_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.82e-041731934237_DN
Druglactide

EDA HMGN4

3.86e-0435192CID000007272
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.88e-041741937105_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.88e-041741935745_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.88e-041741933993_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.88e-041741935940_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.88e-041741935065_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

3.95e-041751933787_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.02e-041761936546_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.08e-041771937047_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.15e-041781934436_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 CHD3

4.22e-041791932105_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.22e-041791935822_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.29e-041801933688_DN
Drugprimidone

EPS8 ELF3

4.32e-0437192CID000004909
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.36e-041811937077_DN
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

EDA KLHL36 ELF3

4.36e-041811931236_UP
DrugSecurinine [5610-40-2]; Up 200; 18.4uM; PC3; HT_HG-U133A

FST ELF3 PTHLH

4.36e-041811934493_UP
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.65e-041851935882_DN
DrugApigenin [520-36-5]; Down 200; 14.8uM; PC3; HT_HG-U133A

PHF2 ZNF365 PTHLH

4.72e-041861934578_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

4.72e-041861936874_DN
Drug2-deoxy-D-glucose; Up 200; 10000uM; MCF7; HG-U133A

SMARCA2 HMGN4 RRP12

4.72e-04186193344_UP
Drug17-AAG; Up 200; 1uM; PC3; HT_HG-U133A

ZNF365 KLHL36 PTHLH

4.80e-041871931218_UP
DrugEburnamonine (-) [4880-88-0]; Down 200; 13.6uM; PC3; HT_HG-U133A

PHF2 ZNF365 CHD3

5.02e-041901937154_DN
DrugCP-690334-01 [459212-38-5]; Down 200; 10uM; PC3; HT_HG-U133A

FST PHF2 PTHLH

5.10e-041911933823_DN
DrugLY 294002; Up 200; 10uM; PC3; HT_HG-U133A

SMARCA2 KLHL36 ELF3

5.10e-041911931227_UP
DrugFludrocortisone acetate [514-36-3]; Up 200; 9.4uM; HL60; HT_HG-U133A

SMARCA2 CHD3 RRP12

5.10e-041911932368_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; MCF7; HG-U133A

FST HMGN4 ELF3

5.18e-0419219323_UP
Drug2-propylpentanoic acid; Up 200; 1000uM; PC3; HT_HG-U133A

SMARCA2 ZNF365 BAHCC1

5.18e-041921931209_UP
DrugDanazol [17230-88-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A

EDA ZNF365 ELF3

5.26e-041931935315_UP
Drugmethyl-ene

EDA HMGN4

5.31e-0441192CID000123164
DrugCyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A

SMARCA2 CHD3 RRP12

5.34e-041941934572_DN
DrugNadide [53-84-9]; Up 200; 6uM; PC3; HT_HG-U133A

SMARCA2 PTHLH BAHCC1

5.34e-041941935873_UP
DrugPyrantel tartrate [33401-94-4]; Up 200; 11.2uM; HL60; HG-U133A

ELF3 RRP12 BAHCC1

5.34e-041941931413_UP
DrugPhenacetin [62-44-2]; Down 200; 22.4uM; MCF7; HT_HG-U133A

EDA RRP12 BAHCC1

5.34e-041941934111_DN
DrugGliquidone [33342-05-1]; Up 200; 7.6uM; HL60; HT_HG-U133A

FST ZNF365 KLHL36

5.34e-041941933126_UP
DrugFuraltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A

SMARCA2 PTHLH BAHCC1

5.34e-041941933932_DN
DrugLevamisole hydrochloride [16595-80-5]; Up 200; 16.6uM; HL60; HG-U133A

KLHL36 RRP12 BAHCC1

5.42e-041951931410_UP
DrugDyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A

EDA KLHL36 CHD3

5.42e-041951937022_UP
DrugPalmatine chloride [3486-67-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A

PTHLH CHD3 BAHCC1

5.42e-041951932795_UP
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; MCF7; HT_HG-U133A

EDA PTHLH CHD3

5.42e-041951934117_DN
Drugmonastrol; Down 200; 100uM; MCF7; HG-U133A

RBBP5 HMGN4 RRP12

5.42e-04195193681_DN
DrugFusaric acid [536-69-6]; Up 200; 22.4uM; PC3; HT_HG-U133A

EDA KLHL36 RRP12

5.50e-041961933986_UP
DrugIndomethacin [53-86-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A

SMARCA2 EDA BAHCC1

5.50e-041961937409_UP
Drugprobucol; Up 200; 10uM; MCF7; HG-U133A

CHD3 RRP12 BAHCC1

5.50e-04196193592_UP
Drug0179445-0000 [211246-22-9]; Down 200; 1uM; PC3; HT_HG-U133A

KLHL36 CHD3 BAHCC1

5.50e-041961934292_DN
Drugamitriptyline hydrochloride; Down 200; 1uM; MCF7; HG-U133A

FST RRP12 BAHCC1

5.50e-04196193167_DN
DrugNorethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A

SMARCA2 KLHL36 CHD3

5.50e-041961931696_DN
DrugNalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

ZNF365 PTHLH BAHCC1

5.50e-041961932225_DN
DrugSB 202190; Up 200; 1uM; MCF7; HT_HG-U133A

EDA ZNF365 CHD3

5.50e-041961937054_UP
DrugMetergoline [17692-51-2]; Down 200; 10uM; HL60; HG-U133A

CHD3 RRP12 EBNA1BP2

5.50e-041961931606_DN
DrugSulfaguanidine [57-67-0]; Down 200; 18.6uM; HL60; HG-U133A

PHF2 EDA RBBP5

5.50e-041961931995_DN
Drug(-)-quinpirole hydrochloride; Up 200; 1uM; MCF7; HG-U133A

KLHL36 RRP12 BAHCC1

5.58e-04197193456_UP
Drugalpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A

EDA PTHLH BAHCC1

5.58e-041971935207_UP
DrugMexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; PC3; HT_HG-U133A

KLHL36 RRP12 BAHCC1

5.58e-041971933781_DN
DrugThioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A

SMARCA2 ZNF365 CHD3

5.58e-041971936265_UP
DrugPHA-00767505E [723337-45-9]; Down 200; 10uM; PC3; HT_HG-U133A

KLHL36 CHD3 RRP12

5.58e-041971936545_DN
DrugSC-58125; Up 200; 10uM; HL60; HG-U133A

FST CHD3 RRP12

5.58e-04197193542_UP
DrugBergenin monohydrate [477-90-7]; Up 200; 11.6uM; PC3; HT_HG-U133A

EDA KLHL36 BAHCC1

5.66e-041981935870_UP
DrugPiracetam [7491-74-9]; Up 200; 28.2uM; HL60; HG-U133A

ELF3 RRP12 BAHCC1

5.66e-041981931710_UP
DrugPrazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; PC3; HT_HG-U133A

SMARCA2 KLHL36 BAHCC1

5.66e-041981936315_UP
DrugBetazole hydrochloride; Down 200; 27uM; MCF7; HT_HG-U133A

SMARCA2 KLHL36 CHD3

5.66e-041981931690_DN
DrugTrihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A

EDA RRP12 BAHCC1

5.66e-041981934133_DN
DrugSulfisoxazole [127-69-5]; Down 200; 15uM; PC3; HT_HG-U133A

SMARCA2 ELF3 RRP12

5.66e-041981934661_DN
DrugTrimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A

SMARCA2 FST BAHCC1

5.66e-041981931502_UP
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

SMARCA2 ZNF365 KLHL36

5.66e-041981933551_DN
DrugIoversol [87771-40-2]; Down 200; 5uM; PC3; HT_HG-U133A

KLHL36 ELF3 RRP12

5.66e-041981936726_DN
DrugCarbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A

SMARCA2 ELF3 CHD3

5.75e-041991934649_DN
DrugFolinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; PC3; HT_HG-U133A

SMARCA2 KLHL36 CHD3

5.75e-041991937401_DN
DrugIvermectin [70288-86-7]; Up 200; 4.6uM; PC3; HT_HG-U133A

SMARCA2 ELF3 BAHCC1

5.75e-041991935853_UP
DrugAlfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; HL60; HG-U133A

SMARCA2 FST CHD3

5.75e-041991931586_DN
DrugBenoxinate hydrochloride [5987-82-6]; Down 200; 11.6uM; MCF7; HT_HG-U133A

SMARCA2 CHD3 RRP12

5.83e-042001931476_DN
DrugHaloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A

FST PHF2 EDA

5.83e-042001932039_DN
Drugdeme

SMARCA2 FST

6.68e-0446192CID000152803
Drugdoxifluridine

EPS8 ELF3

7.89e-0450192ctd:C025034
Diseaseessential hypertension, age at diagnosis

REXO1 BAHCC1

5.93e-0456192EFO_0004918, MONDO_0001134
Diseasebreast size

ZNF365 PTHLH

8.98e-0469192EFO_0004884
Diseaseestrogen-receptor negative breast cancer

ZNF365 PTHLH

9.51e-0471192EFO_1000650
Diseaseforced expiratory volume

SMARCA2 HMGN4 ZNF365 PTHLH

1.43e-03789194EFO_0004314
DiseaseAbortion, Tubal

FST PTHLH

2.22e-03109192C0000822
DiseaseEarly Pregnancy Loss

FST PTHLH

2.22e-03109192C3830362
DiseaseMiscarriage

FST PTHLH

2.22e-03109192C4552766
DiseaseSpontaneous abortion

FST PTHLH

2.22e-03109192C0000786
Diseasefacial morphology measurement

PHF2 EDA PTHLH

3.14e-03466193EFO_0007841
Diseasebreast carcinoma

FST ZNF365 PTHLH BAHCC1

3.62e-031019194EFO_0000305
DiseaseMammary Neoplasms, Human

FST ZNF365 PTHLH

4.39e-03525193C1257931
DiseaseMammary Carcinoma, Human

FST ZNF365 PTHLH

4.39e-03525193C4704874
DiseaseMammary Neoplasms

FST ZNF365 PTHLH

4.44e-03527193C1458155
DiseaseBreast Carcinoma

FST ZNF365 PTHLH

4.70e-03538193C0678222
Diseasebrain measurement, neuroimaging measurement

SMARCA2 RBBP5 BAHCC1

5.00e-03550193EFO_0004346, EFO_0004464
Diseaseage at menarche

SMARCA2 FST REXO1

6.19e-03594193EFO_0004703
Diseaseprostate specific antigen measurement

EDA CHD3

6.43e-03188192EFO_0004624
Diseasealcohol use disorder (implicated_via_orthology)

SMARCA2 EPS8

6.90e-03195192DOID:1574 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
PPGALGKKKAKGKAK

BAHCC1

1746

Q9P281
KKGDPKHGKRKRGRP

ELF3

236

P78545
EPRPEDKKKKGKGKR

KLHL36

596

Q8N4N3
LKRPGKKGSNKRPGK

EBNA1BP2

281

Q99848
AKKGEKLPKGRKGKA

HMGN4

46

O00479
GPGKKCRMNKKNKPR

FST

101

P19883
KKQAGRPKGSKGKEK

RBBP5

481

Q15291
KNKKKGKKAGPPGPN

EDA

171

Q92838
KRGPKKQKENKPGKP

CHD3

51

Q12873
AKGGKKKKDPNAPKR

HMGB3

81

O15347
KKNKKGKRKGPGEGV

EPS8

301

Q12929
QDGGCPKEGKPKKKK

REXO1

366

Q8N1G1
PPPKKKKKKKGGHRR

SRRM3

166

A6NNA2
RPPKTLKLKDGGKKK

PHF2

516

O75151
KGKGKKRPNRGKAKP

SMARCA2

1551

P51531
KKAKGDVKKKGRPDP

RRP12

1236

Q5JTH9
GRKGNIRPKMAKKKP

ZNF365

386

Q70YC5
TPGKKKKGKPGKRKE

PTHLH

121

P12272
PHRGGRPNKKKKFKG

TRIM56

451

Q9BRZ2